Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lung Cancer Incidence in Patients With Type 2 Diabetes and COPD: A Real-World Retrospective Cohort Study Comparing SGLT2 Inhibitors and Sulfonylureas

NCT07332156 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT07332156
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07332156 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lung Cancer Incidence in Patients With Type 2 Diabetes and COPD: A Real-World Retrospective Cohort Study Comparing SGLT2 Inhibitors and Sulfonylureas
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Completed
Start date
January 1, 2009
Completion date
December 31, 2023
Enrollment
21,692 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

copd (chronic obstructive pulmonary disease), lung cancer (diagnosis), type 2 diabetes